Accurate distinction of pathogenic from benign CNVs in mental retardation.

Copy number variants (CNVs) have recently been recognized as a common form of genomic variation in humans. Hundreds of CNVs can be detected in any individual genome using genomic microarrays or whole genome sequencing technology, but their phenotypic consequences are still poorly understood. Rare CN...

Full description

Bibliographic Details
Main Authors: Hehir-Kwa, J, Wieskamp, N, Webber, C, Pfundt, R, Brunner, H, Gilissen, C, de Vries, B, Ponting, C, Veltman, J
Format: Journal article
Language:English
Published: Public Library of Science 2010
_version_ 1797084199867383808
author Hehir-Kwa, J
Wieskamp, N
Webber, C
Pfundt, R
Brunner, H
Gilissen, C
de Vries, B
Ponting, C
Veltman, J
author_facet Hehir-Kwa, J
Wieskamp, N
Webber, C
Pfundt, R
Brunner, H
Gilissen, C
de Vries, B
Ponting, C
Veltman, J
author_sort Hehir-Kwa, J
collection OXFORD
description Copy number variants (CNVs) have recently been recognized as a common form of genomic variation in humans. Hundreds of CNVs can be detected in any individual genome using genomic microarrays or whole genome sequencing technology, but their phenotypic consequences are still poorly understood. Rare CNVs have been reported as a frequent cause of neurological disorders such as mental retardation (MR), schizophrenia and autism, prompting widespread implementation of CNV screening in diagnostics. In previous studies we have shown that, in contrast to benign CNVs, MR-associated CNVs are significantly enriched in genes whose mouse orthologues, when disrupted, result in a nervous system phenotype. In this study we developed and validated a novel computational method for differentiating between benign and MR-associated CNVs using structural and functional genomic features to annotate each CNV. In total 13 genomic features were included in the final version of a Naïve Bayesian Tree classifier, with LINE density and mouse knock-out phenotypes contributing most to the classifier's accuracy. After demonstrating that our method (called GECCO) perfectly classifies CNVs causing known MR-associated syndromes, we show that it achieves high accuracy (94%) and negative predictive value (99%) on a blinded test set of more than 1,200 CNVs from a large cohort of individuals with MR. These results indicate that this classification method will be of value for objectively prioritizing CNVs in clinical research and diagnostics.
first_indexed 2024-03-07T01:52:03Z
format Journal article
id oxford-uuid:9a73387c-0026-4aae-9c1f-afff33e1d83a
institution University of Oxford
language English
last_indexed 2024-03-07T01:52:03Z
publishDate 2010
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:9a73387c-0026-4aae-9c1f-afff33e1d83a2022-03-27T00:21:22ZAccurate distinction of pathogenic from benign CNVs in mental retardation.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:9a73387c-0026-4aae-9c1f-afff33e1d83aEnglishSymplectic Elements at OxfordPublic Library of Science2010Hehir-Kwa, JWieskamp, NWebber, CPfundt, RBrunner, HGilissen, Cde Vries, BPonting, CVeltman, JCopy number variants (CNVs) have recently been recognized as a common form of genomic variation in humans. Hundreds of CNVs can be detected in any individual genome using genomic microarrays or whole genome sequencing technology, but their phenotypic consequences are still poorly understood. Rare CNVs have been reported as a frequent cause of neurological disorders such as mental retardation (MR), schizophrenia and autism, prompting widespread implementation of CNV screening in diagnostics. In previous studies we have shown that, in contrast to benign CNVs, MR-associated CNVs are significantly enriched in genes whose mouse orthologues, when disrupted, result in a nervous system phenotype. In this study we developed and validated a novel computational method for differentiating between benign and MR-associated CNVs using structural and functional genomic features to annotate each CNV. In total 13 genomic features were included in the final version of a Naïve Bayesian Tree classifier, with LINE density and mouse knock-out phenotypes contributing most to the classifier's accuracy. After demonstrating that our method (called GECCO) perfectly classifies CNVs causing known MR-associated syndromes, we show that it achieves high accuracy (94%) and negative predictive value (99%) on a blinded test set of more than 1,200 CNVs from a large cohort of individuals with MR. These results indicate that this classification method will be of value for objectively prioritizing CNVs in clinical research and diagnostics.
spellingShingle Hehir-Kwa, J
Wieskamp, N
Webber, C
Pfundt, R
Brunner, H
Gilissen, C
de Vries, B
Ponting, C
Veltman, J
Accurate distinction of pathogenic from benign CNVs in mental retardation.
title Accurate distinction of pathogenic from benign CNVs in mental retardation.
title_full Accurate distinction of pathogenic from benign CNVs in mental retardation.
title_fullStr Accurate distinction of pathogenic from benign CNVs in mental retardation.
title_full_unstemmed Accurate distinction of pathogenic from benign CNVs in mental retardation.
title_short Accurate distinction of pathogenic from benign CNVs in mental retardation.
title_sort accurate distinction of pathogenic from benign cnvs in mental retardation
work_keys_str_mv AT hehirkwaj accuratedistinctionofpathogenicfrombenigncnvsinmentalretardation
AT wieskampn accuratedistinctionofpathogenicfrombenigncnvsinmentalretardation
AT webberc accuratedistinctionofpathogenicfrombenigncnvsinmentalretardation
AT pfundtr accuratedistinctionofpathogenicfrombenigncnvsinmentalretardation
AT brunnerh accuratedistinctionofpathogenicfrombenigncnvsinmentalretardation
AT gilissenc accuratedistinctionofpathogenicfrombenigncnvsinmentalretardation
AT devriesb accuratedistinctionofpathogenicfrombenigncnvsinmentalretardation
AT pontingc accuratedistinctionofpathogenicfrombenigncnvsinmentalretardation
AT veltmanj accuratedistinctionofpathogenicfrombenigncnvsinmentalretardation